PAULA (Policy-Augmented Utilization Logic Agent) is a physician-led AI platform that turns complex payer policies, CMS updates, and state AI regulations into structured operational intelligence for hospital utilization review teams, physician advisors, and revenue cycle leaders.

How does PAULA help reduce claim denials?

PAULA decomposes payer rules, CMS updates, and reimbursement shifts into structured logic cards and denial-risk signals, helping UR teams identify recoverable assets, cite applicable state laws in appeals, and act on regulatory changes before competitors.

What types of healthcare organizations use PAULA?

PAULA is designed for hospital utilization review directors, physician advisors, CFOs, compliance officers, and risk executives at health systems of all sizes seeking to protect revenue and navigate AI governance requirements.

How does PAULA track state AI legislation?

PAULA monitors 240+ state AI bills across 43 states in real time, surfacing jurisdiction-specific rules that create legal grounds to challenge AI-generated payer denials and converting them into Monday-morning action items for UR teams.

Is PAULA affiliated with any payer organization?

No. PAULA has zero payer affiliation. It was built by a physician who worked on both sides of the utilization review process and decided the conflict of interest was a problem worth solving.

What is the OIG investigation PAULA helps with?

PAULA surfaces federal enforcement signals like OIG investigation OEI-09-24-00332, which examines Medicare Advantage post-acute denial rates, and translates them into operational playbooks for recovering previously unappealed denials.

How does PAULA support AI governance and compliance?

PAULA provides audit trail support including decision logs, version control, escalation records, clinician review pathways, and documentation of AI output generation — essential for explainability under evolving federal and state AI regulations.

What briefings does PAULA provide?

PAULA delivers role-specific policy intelligence briefings covering prior authorization rules, CMS updates, state AI legislation, Medicare Advantage compliance, and denial recovery opportunities — tailored for Physician Advisors, UM leaders, CFOs, and Compliance teams.

How is PAULA different from other utilization review tools?

Unlike payer-affiliated UM tools, PAULA was built by a physician with no payer conflict of interest, combining real-time regulatory tracking with structured clinical intelligence to give providers a level playing field in the denial management process.

How do I get started with PAULA?

You can assess your denial exposure and request a demo directly at paula.clinefficiency.pro by clicking the Assess Your Exposure button, or contact the team to schedule a consultation.

What changed with AI-driven denials and human-review documentation?

CMS-4201-F (42 CFR §422.101(c)) prohibits Medicare Advantage plans from using algorithms or software that fail to account for an individual beneficiary's circumstances as the sole basis for adverse coverage decisions. ONC HTI-1 transparency rules and HHS OCR §1557 layer transparency and anti-discrimination obligations on every AI-assisted UM workflow. Every AI-assisted denial now demands contemporaneous human-review attestation: reviewer identity, qualifications, patient-specific factors, and explicit advisory-only language.

When do the AI-in-UM human-review requirements take effect?

CMS-4201-F is effective plan year 2024 onward, reinforced by the CMS FAQ memo (February 2024). ONC HTI-1 and HHS OCR §1557 final rules were issued in 2024. State laws — CA SB 1120 (Jan 1, 2025), IL HB 5395, OK SB 303, CO SB 24-205 — layer on with their own effective dates.

Who is affected by the AI-driven denial human-review rules?

Medicare Advantage plans, Commercial / ERISA payers, and Medicaid MCOs — and the hospitals and providers that submit prior auth, medical necessity, and documentation through them. Service lines most exposed: prior auth, medical necessity, and clinical documentation.

PAULA · INTEL

Critical Denial RiskRevenue at Risk: $1.4M–$2.6M (est)Effective Now · CMS-4201-F

AI-Driven Denials Now Require Defensible Human-Review Documentation

CMS-4201-F prohibits Medicare Advantage plans from using algorithms as the sole basis for adverse coverage decisions. ONC HTI transparency rules and HHS OCR §1557 expand the legal exposure of unaudited AI in UM workflows. Every AI-assisted denial now demands contemporaneous human-review attestation — reviewer identity, qualifications, patient-specific factors, and explicit advisory-only language.

Published by the PAULA Intelligence Team|Reviewed by a board-certified Physician Advisor

Affected Payers

· Medicare Advantage
· Commercial / ERISA
· Medicaid MCO

Service Lines

· Prior Auth
· Medical Necessity
· Documentation

01 — Signal

Why PAULA flagged this

CMS-4201-F (effective plan year 2024 onward) prohibits MA organizations from using algorithms or software that fail to account for an individual beneficiary's circumstances as the sole basis for coverage decisions. ONC's HTI-1 rule and HHS OCR's §1557 final rule layer transparency and anti-discrimination obligations on every AI-assisted UM workflow. State laws (CA SB 1120, IL HB 5395, OK SB 303, CO SB 24-205) require licensed physician review and prohibit AI-only denials.

Recommended Action — Within 30 Days

Add human-review attestation language to every denial appeal and require documented clinical rationale before submission. Template a Physician Advisor note in the EHR capturing reviewer identity, qualifications, patient-specific factors, and explicit advisory-only language for every AI-flagged determination.

Locked · Full Brief

Scenarios, defenses, P2P scripts, executive lenses, and payer impact unlock with any briefing tier.

02 — Full Analysis

What the AI-in-UM regulatory floor now requires

CMS FAQ guidance (Feb 2024) and the Senate PSI majority staff report on MA prior authorization made clear that nH Predict-style models, when used to override clinical judgment, expose plans to MA contract enforcement and False Claims Act risk. ONC's HTI-1 final rule (2024) and HTI-2 NPRM expanded transparency requirements for Predictive DSI used in certified health IT — including UM workflows that touch certified EHRs. HHS OCR's §1557 final rule (May 2024) prohibits algorithmic discrimination in covered health programs.

Plaintiff's bar has noticed — Lokken v. UnitedHealth Group (nH Predict) and similar class actions are testing the boundaries. For provider-side compliance: every AI-assisted denial must be accompanied by contemporaneous documentation showing (1) the human reviewer's identity and qualifications, (2) the patient-specific clinical factors considered, (3) the reviewer's independent rationale, and (4) confirmation that the AI/algorithm was advisory, not determinative.

03 — Denial Scenarios PAULA is Watching

Three high-probability denial patterns

PAULA inference based on payer behavior patterns and the source rule's structure — not directly quoted in the regulatory text. Verify against current payer policy before citing in an appeal.

Scenario · 01

MA Post-Acute Denial Citing Algorithm Output Without Individualized Review

Payer Argument

(Inferred) MA plan issues a post-acute or inpatient denial whose letter references a model score, predictive tool, or length-of-stay benchmark without identifying a licensed reviewer or documenting beneficiary-specific clinical factors.

Defense

Audit the denial letter for any reference to algorithm, model, score, or predictive tool. Cite CMS-4201-F §422.101(c) and demand the human reviewer's name, credential, and patient-specific rationale on the record. Escalate to plan medical director peer-to-peer and preserve the letter as evidence for FCA and MA contract enforcement.

P2P Framing

'Per CMS-4201-F (42 CFR §422.101(c)), an MA plan cannot use an algorithm as the sole basis for an adverse coverage determination. Please identify on the record the licensed reviewer who made this decision, their qualifications, and the patient-specific clinical factors they considered. Until that record exists, the denial does not satisfy the regulatory floor and we will pursue overturn and complaint remedies.'

Scenario · 02

Pattern Denials Suggesting §1557 Algorithmic Discrimination Exposure

Payer Argument

(Inferred) A payer issues a cluster of denials in a protected-class population at rates inconsistent with comparable cohorts — the pattern suggests the underlying algorithm was not bias-tested or that its training data systematically under-serves the affected population.

Defense

Trigger a §1557 algorithmic-discrimination preservation letter; demand the determination basis under CMS-4201-F transparency obligations; file state DOI complaints where applicable (CA, IL, OK, NY, CO, TX). Preserve the denial cohort for OCR submission and bias-testing discovery.

P2P Framing

'Under HHS OCR §1557, covered programs cannot use algorithms that produce discriminatory outcomes. Please produce the bias-testing documentation for the tool that generated this determination, identify the licensed reviewer, and explain how patient-specific factors were weighed. We are preserving this cohort for OCR and DOI review.'

Scenario · 03

EHR Predictive DSI Override Without HTI-1 Source-Attribute Disclosure

Payer Argument

(Inferred) A payer or in-EHR UM tool surfaces a Predictive DSI recommendation that overrides physician judgment without disclosing intended use, training data source, or known limitations as required by ONC HTI-1.

Defense

Capture the DSI screen at the point of override; request HTI-1 source-attribute disclosure from the vendor in writing; document the override decision in the chart with patient-specific factors and explicit advisory-only language.

P2P Framing

'ONC HTI-1 (45 CFR Part 170) requires certified Predictive DSI to disclose its intended use, training data, and limitations. Please provide the source attributes for the tool that drove this recommendation. The treating physician exercised independent clinical judgment based on documented patient-specific factors; the algorithm was advisory only.'

04 — Decision Layer

Three executive lenses

Physician Advisor

Every AI-flagged or AI-influenced denial requires an independent, contemporaneous Physician Advisor note documenting: (1) the patient-specific clinical factors reviewed, (2) the PA's qualifications and license, (3) the rationale for either concurring or overriding the algorithm, and (4) an explicit statement that the AI was advisory only. Template this in the EHR within 14 days and audit attestation completeness weekly.

CFO / Revenue Cycle

Revenue at risk for a 250-bed acute care facility: $1.4M–$2.6M annually across overturned denials, retroactive recoveries, and reduced first-pass denial rates. Build a denial-recovery KPI dashboard segmented by 'AI-influenced' vs 'human-reviewed' denials to expose payer patterns and arm contract negotiations. Tag CMS-4201-F-grounded overturns to quantify ROI on the human-review attestation workflow.

Compliance & Legal

Maintain a CLAIR-governed audit trail of every AI-assisted UM decision, with reviewer credentials, patient-specific factors, and algorithm-disclosure attestations preserved for 7 years. Coordinate with privacy and §1557 compliance teams; brief the board annually on AI-in-UM litigation and enforcement exposure including Lokken v. UnitedHealth, OCR §1557 actions, and active state legislation.

05 — Denial Playbook

Appeal phrasing, levers & citations

Documentation Levers

Physician order and clinical rationale for the requested level of care
Physician Advisor independent review note with patient-specific factors
Medical necessity criteria mapped to InterQual or MCG with patient-specific deviation rationale
Any payer correspondence referencing 'model', 'algorithm', 'AI', 'score', or 'predictive' tooling
EHR screen capture of any DSI recommendation that influenced the order or override decision

What to Cite

CMS-4201-F Final Rule (42 CFR §422.101(c)) — MA & Part D
CMS FAQ memo on Coverage Criteria and Algorithms in MA (Feb 2024)
ONC HTI-1 Final Rule — Predictive DSI transparency (45 CFR Part 170)
HHS OCR §1557 Final Rule — Nondiscrimination in Health Programs
Senate PSI Majority Staff Report — MA Prior Authorization (Oct 2024)
State law: CA SB 1120, IL HB 5395, CO SB 24-205, OK SB 303

06 — Payer Impact

Projected payer behavior

PAULA watch item — projected payer behavior under this rule. Verify against current payer medical policy or provider bulletin.

Medicare Advantage

Critical

CMS-4201-F directly governs MA UM. Expect enforcement letters, audit protocol updates, and contract-level scrutiny of any algorithm-driven adverse determination lacking documented human review.

Commercial / ERISA

High

State law (CA, IL, OK, CO) reaches fully insured commercial plans; ERISA plans face §1557 exposure when receiving federal financial assistance. AI-only denials will increasingly trigger DOI complaints and class action discovery.

Medicaid MCO

High

State Medicaid agencies are adopting parallel AI-in-UM transparency requirements. MCO denial letters lacking licensed reviewer attestation are vulnerable to state fair hearing reversal.

Underwriter Read · Pathway Risk Artifact

How this brief lands across the affected payment pathways

Composed from PAULA's internal Underwriter / CFO intelligence corpus. Each pathway is scored on a five-signal frame — loss frequency, loss severity, signal quality, regulatory volatility, and denial-risk index.

Pathway 6 · MA / commercial VBC

Medicare Advantage / Commercial — Shared Savings, Capitation, and Value-Based Contracts

Severe · 4.7Viability · High

The strongest funding model for UM/CDI AI specifically. Shared savings, capitation, and risk-bearing contracts directly reward denial avoidance, status-determination accuracy, and reduced unnecessary utilization. Self-funds when AI moves the shared-savings number.

Loss Freq

Loss Sev

Signal Qual

Reg Volatility

Denial Risk

Top scenario · AI-Driven Inpatient Admission Challenged as Non-FAVES-Compliant — $7.2M revenue at risk

Pathway 7 · CMMI APM

CMMI Alternative Payment Models — EOM, ACO REACH, and ACCESS

High · 3.5Viability · Emerging

CMMI APMs create financial structures enabling — and in some cases requiring — AI-enabled care delivery, but vary by model. ACO REACH and EOM offer the clearest AI economics today; broader applicability depends on model evolution under the current administration.

Loss Freq

Loss Sev

Signal Qual

Reg Volatility

Denial Risk

Top scenario · AI-Driven Inpatient Admission Challenged as Non-FAVES-Compliant — $7.2M revenue at risk

Source intelligence held internally · Not distributed as a standalone PDF

Operationalize this brief

Choose your briefing tier.

One-time purchase · Delivered as a downloadable executive PDF with citations and CLIP-ready operational templates.

Assess your exposure

Sources: CMS-4201-F Final Rule · 42 CFR §422.101(c) · CMS FAQ memo (Feb 2024) · ONC HTI-1 Final Rule · HHS OCR §1557 Final Rule · Senate PSI Majority Staff Report (Oct 2024). Source Confidence: HIGH — Primary regulatory source. Verify against the underlying rule and current payer policy before formal use.